An unresectable and metastatic intrahepatic cholangiocarcinoma with EML4-ALK rearrangement achieving partial response after first-line treatment with ensartinib: a case report

Overview of attention for article published in Frontiers in oncology, August 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 4 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 7,729 followers.

c cholangiocarcinoma with EML4-ALK rearrangement achieving partial response after first-line treatment with ensartinib: a case report https://t.co/oBnS2LMCFR #CCC

05 Dec 2023

Reply Repost Favourite

RT @FrontOncology: New research: An unresectable and metastatic intrahepatic cholangiocarcinoma with EML4-ALK rearrangement achieving parti…

02 Sep 2023

Reply Repost Favourite

RT @FrontOncology: New research: An unresectable and metastatic intrahepatic cholangiocarcinoma with EML4-ALK rearrangement achieving parti…

02 Sep 2023

Reply Repost Favourite

New research: An unresectable and metastatic intrahepatic cholangiocarcinoma with EML4-ALK rearrangement achieving partial response after first-line treatment with ensartinib: a case report: Systemic chemotherapies are the primary treatment… #oncology http

30 Aug 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.